Skip to main content
. Author manuscript; available in PMC: 2021 Jul 27.
Published in final edited form as: AIChE J. 2020 Oct 2;67(2):e17085.

TABLE 5.

Post-thaw apoptosis of Jurkat cells cryopreserved in NADES, MCO and DMSO solutionsa

CPA solutions Live (%) Early apoptotic (%) Late apoptotic (%) Necrotic (%)
NADES solutions 5% T:G 89.97 ± 0.29 9.03 ± 0.39 0.34 ± 0.17 0.65 ± 0.48
10% T:G 52.37 ± 2.01b 46.40 ± 2.15b 0.58 ± 0.15b 0.68 ± 0.73
15% T:G 47.07 ± 7.52b 50.83 ± 8.61b 1.29 ± 0.16b 0.80 ± 0.89
5% T:G + 10.75 mM isoleucine 94.97 ± 0.52b 4.45 ± 0.33b 0.22 ± 0.087 0.37 ± 0.18
5% T:G + 21.5 mM isoleucine 88.70 ± 0.25b 10.43 ± 0.14b 0.42 ± 0.20 0.42 ± 0.11
5% T:G + 43 mM isoleucine 80.80 ± 0.90b 18.03 ± 0.76b 0.62 ± 0.38b 0.50 ± 0.13
TGI (MCO) 90.30 ± 1.14b 8.91 ± 1.29b 0.36 ± 0.029 0.42 ± 0.19
10% DMSO 92.87 ± 0.14b 5.90 ± 3.19b 0.27 ± 0.12 0.32 ± 0.28

Abbreviations: CPA, cryoprotective agents; DMSO, dimethyl sulfoxide; NADES, natural deep eutectic system; T:G, NADES composed of trehalose and glycerol at 1:30 M ratio; TGI or MCO, a multicomponent osmolyte solution containing trehalose, glycerol, and isoleucine.

a

95% confidence interval calculated from three independent replicates for each sample using a T distribution. Fresh Jurkat cells in culture were 99.1% live, 0.29% early apoptotic, 0.03% late apoptotic, and 0.56% necrotic.

b

p < .05 in two-sample comparison with 5% T:G.